Download PDF
Thromb Haemost
DOI: 10.1055/a-2593-1679
Stroke, Systemic or Venous Thromboembolism

Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study

Oda G.R. Leknessund 
1   Department of Clinical Medicine, Thrombosis Research Group, UiT—the Arctic University of Norway, Troms, Norway
,
John-Bjarne Hansen
1   Department of Clinical Medicine, Thrombosis Research Group, UiT—the Arctic University of Norway, Troms, Norway
2   Division of Internal Medicine, Thrombosis Research Center, University Hospital of North Norway, Troms, Norway
,
Sigrid K. Brækkan
1   Department of Clinical Medicine, Thrombosis Research Group, UiT—the Arctic University of Norway, Troms, Norway
2   Division of Internal Medicine, Thrombosis Research Center, University Hospital of North Norway, Troms, Norway
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints


Abstract

Background

While resting heart rate (RHR) is associated with multiple diseases, conflicting information exists on the association between RHR and venous thromboembolism (VTE). We, therefore, aimed to investigate the association between RHR and risk of VTE in a population-based cohort.

Methods

Participants (n = 36,395) were followed from inclusion in the Tromsø 4 to 7 surveys (1994–2016) throughout 2020. RHR was measured in beats per minute (bpm) at each survey (repeated measurements for those attending several surveys). All first-time VTEs during follow-up were recorded. Hazard ratios (HR) for VTE with 95% confidence intervals (CIs) according to RHR categories (61–70, 71–80, and >80 bpm) with ≤60 bpm as reference were estimated using Cox regression models, and adjusted for age, sex, body mass index, cardiovascular disease, cancer, and physical activity. We also performed age-stratified analyses (<60 and ≥60 years).

Results

During a median of 6.6 years of follow-up, 1,072 participants experienced a VTE. Fully adjusted HRs (95% CI) for overall VTE were 1.12 (0.93–1.35), 1.35 (1.11–1.63), and 1.19 (0.97–1.47) for RHR categories 61 to 70, 71 to 80, and >80 bpm, respectively. Corresponding HRs for unprovoked VTE were 1.56 (1.14–2.14), 1.76 (1.28–2.43), and 1.60 (1.13–2.25), whereas no association was observed for provoked VTE. The association was more consistent in those ≥60 years, with HRs for overall VTE, >80 bpm versus ≤60 bpm of 1.30 (1.02–1.65) and for unprovoked VTE of 1.86 (1.24–2.81).

Conclusion

Our findings suggest that higher RHR may be a risk factor for VTE and more consistently so for those ≥60 years. The VTE risk by higher RHR was particularly pronounced for unprovoked events.

Keywords

venous thrombosis - deep vein thrombosis - pulmonary embolism - resting heart rate - unprovoked venous thrombosis

Authors' Contribution

Conception and design: J.B.H., S.K.B. Statistical analysis: O.G.R.L., S.K.B. Interpretation of results: O.G.R.L., J.B.H., S.K.B. Draft of manuscript: O.G.R.L. Critical revision of manuscript: S.K.B., J.B.H. Approval of submitted version: all authors.


Supplementary Material



Publication History

Received: 12 April 2024

Accepted: 23 April 2025

Accepted Manuscript online:
24 April 2025

Article published online:
08 May 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet 2021; 398 (10294): 64-77
    CrossrefPubMedSearch in Google Scholar
  • 2 Utne KK, Tavoly M, Wik HS. et al. Health-related quality of life after deep vein thrombosis. Springerplus 2016; 5 (01) 1278
    CrossrefPubMedSearch in Google Scholar
  • 3 Prandoni P, Lensing AW, Cogo A. et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125 (01) 1-7
    CrossrefPubMedSearch in Google Scholar
  • 4 Schulman S, Lindmarker P, Holmström M. et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4 (04) 734-742
    CrossrefPubMedSearch in Google Scholar
  • 5 Becattini C, Agnelli G, Pesavento R. et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006; 130 (01) 172-175
    PubMedSearch in Google Scholar
  • 6 Jørgensen H, Horváth-Puhó E, Laugesen K, Brækkan S, Hansen J-B, Sørensen HT. Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: a population-based cohort study. PLoS Med 2021; 18 (08) e1003770
    CrossrefPubMedSearch in Google Scholar
  • 7 Bell EJ, Lutsey PL, Basu S. et al. Lifetime risk of venous thromboembolism in two cohort studies. Am J Med 2016; 129 (03) 339.e19-339.e26
    CrossrefPubMedSearch in Google Scholar
  • 8 Arnesen CAL, Veres K, Horváth-Puhó E, Hansen J-B, Sørensen HT, Brækkan SK. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death. Eur J Epidemiol 2022; 37 (02) 195-203
    CrossrefPubMedSearch in Google Scholar
  • 9 Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing G-J, Kyrle PA. Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 2016; 14 (07) 1480-1483
    CrossrefPubMedSearch in Google Scholar
  • 10 Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. Eur J Prev Cardiol 2012; 19 (01) 102-108
    PubMedSearch in Google Scholar
  • 11 Jensen MT, Suadicani P, Hein HO, Gyntelberg F. Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the Copenhagen Male Study. Heart 2013; 99 (12) 882-887
    PubMedSearch in Google Scholar
  • 12 Awotoye J, Fashanu OE, Lutsey PL, Zhao D, O'Neal WT, Michos ED. Resting heart rate and incident venous thromboembolism: the multi-ethnic study of atherosclerosis. Open Heart 2020; 7 (01) e001080
    PubMedSearch in Google Scholar
  • 13 Aladin AI, Al Rifai M, Rasool SH. et al. The association of resting heart rate and incident hypertension: the Henry Ford Hospital Exercise Testing (FIT) Project. Am J Hypertens 2016; 29 (02) 251-257
    PubMedSearch in Google Scholar
  • 14 Whelton SP, Narla V, Blaha MJ. et al. Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2014; 113 (04) 644-649
    PubMedSearch in Google Scholar
  • 15 Aune D, Sen A, ó'Hartaigh B. et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 2017; 27 (06) 504-517
    CrossrefPubMedSearch in Google Scholar
  • 16 Aladin AI, Whelton SP, Al-Mallah MH. et al. Relation of resting heart rate to risk for all-cause mortality by gender after considering exercise capacity (the Henry Ford exercise testing project). Am J Cardiol 2014; 114 (11) 1701-1706
    PubMedSearch in Google Scholar
  • 17 Folsom AR, Lutsey PL, Pope ZC. et al; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Resting heart rate and incidence of venous thromboembolism. Res Pract Thromb Haemost 2019; 4 (02) 238-246
    PubMedSearch in Google Scholar
  • 18 Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso Study. Int J Epidemiol 2012; 41 (04) 961-967
    CrossrefPubMedSearch in Google Scholar
  • 19 Hopstock LA, Grimsgaard S, Johansen H, Kanstad K, Wilsgaard T, Eggen AE. The seventh survey of the Tromsø Study (Tromsø7) 2015-2016: study design, data collection, attendance, and prevalence of risk factors and disease in a multipurpose population-based health survey. Scand J Public Health 2022; 50 (07) 919-929
    PubMedSearch in Google Scholar
  • 20 Sharashova E, Wilsgaard T, Brenn T. Resting heart rate on the decline: the Tromsø Study 1986-2007. Int J Epidemiol 2015; 44 (03) 1007-1017
    PubMedSearch in Google Scholar
  • 21 Eggen AE, Mathiesen EB, Wilsgaard T, Jacobsen BK, Njølstad I. The sixth survey of the Tromso Study (Tromso 6) in 2007-08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health 2013; 41 (01) 65-80
    CrossrefPubMedSearch in Google Scholar
  • 22 Evensen LH, Brækkan SK, Hansen JB. Regular physical activity and risk of venous thromboembolism. Semin Thromb Hemost 2018; 44 (08) 765-779
    Thieme ConnectPubMedSearch in Google Scholar
  • 23 Evensen LH, Isaksen T, Braekkan SK, Hansen J-B. Cardiorespiratory fitness and future risk of venous thromboembolism. J Thromb Haemost 2019; 17 (12) 2160-2168
    PubMedSearch in Google Scholar
  • 24 Horvei LD, Grimnes G, Hindberg K. et al. C-reactive protein, obesity, and the risk of arterial and venous thrombosis. J Thromb Haemost 2016; 14 (08) 1561-1571
    CrossrefPubMedSearch in Google Scholar
  • 25 Leknessund OGR, Morelli VM, Strand BH, Hansen JB, Brækkan SK. Hand grip strength and risk of incident venous thromboembolism: the Tromsø study. Res Pract Thromb Haemost 2022; 6 (07) e12833
    PubMedSearch in Google Scholar
  • 26 Leknessund OGR, Morelli VM, Hansen JB, Brækkan SK. Hand grip strength in venous thromboembolism: risk of recurrence and mortality. Res Pract Thromb Haemost 2023; 7 (05) 102138
    PubMedSearch in Google Scholar
  • 27 Braekkan SK, Grosse SD, Okoroh EM. et al. Venous thromboembolism and subsequent permanent work-related disability. J Thromb Haemost 2016; 14 (10) 1978-1987
    CrossrefPubMedSearch in Google Scholar
  • 28 Reimers AK, Knapp G, Reimers CD. Effects of exercise on the resting heart rate: a systematic review and meta-analysis of interventional studies. J Clin Med 2018; 7 (12) 503
    PubMedSearch in Google Scholar
  • 29 Richardson TG, Harrison S, Hemani G, Davey Smith G. An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome. eLife 2019; 8: e43657
    PubMedSearch in Google Scholar
  • 30 von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65 (06) 357-369
    CrossrefPubMedSearch in Google Scholar
  • 31 Cines DB, Pollak ES, Buck CA. et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91 (10) 3527-3561
    PubMedSearch in Google Scholar
  • 32 Lip GY. Does atrial fibrillation confer a hypercoagulable state?. Lancet 1995; 346 (8986) 1313-1314
    PubMedSearch in Google Scholar
  • 33 Khan AA, Lip GYH. The prothrombotic state in atrial fibrillation: pathophysiological and management implications. Cardiovasc Res 2019; 115 (01) 31-45
    CrossrefPubMedSearch in Google Scholar
  • 34 Tilly MJ, Geurts S, Pezzullo AM. et al. The association of coagulation and atrial fibrillation: a systematic review and meta-analysis. Europace 2023; 25 (01) 28-39
    PubMedSearch in Google Scholar
  • 35 Yusuf J, Goyal M, Mukhopadhyay S. et al. Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation–a pilot study. Indian Heart J 2015; 67 (Suppl 2, Suppl 2) S40-S45
    PubMedSearch in Google Scholar
  • 36 Bioengineering NIoBIa. Getting an accurate read on pulse oximeters. NIH MedlinePlus 2023; 18: 4
    PubMedSearch in Google Scholar
  • 37 Clarke R, Shipley M, Lewington S. et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150 (04) 341-353
    CrossrefPubMedSearch in Google Scholar